Clinical Review

Ovarian masses: Surgery or surveillance?

Author and Disclosure Information

 

References

CASE 3 Woman with postmenopausal bleeding seeks medical care

A 62-year-old woman is referred with new-onset postmenopausal spotting for 1 month. She was recently prescribed antibiotics for diverticulitis. She has no family history of cancer. The referring physician included the results of a serum CA 125, which was 48 U/mL (normal, ≤35 U/mL). On pelvic examination, a mobile cystic mass is noted in the posterior cul-de-sac.

Use the stepwise protocol to sort out findings

Step 1. Pelvic ultrasonography. Transvaginal sonography suggested the presence of an endometrial polyp and revealed a 6-cm (volume, 89 mL) septate ovarian cyst (FIGURE 6).

Based on morphology classification, risk was categorized as:

  • simple rules: M rules negative; B2, B4, B5 positive (benign; low risk)
  • ADNEX: 2.9% risk of malignancy (low risk)
  • MI: 2 (low risk).

Step 2. No secondary testing was recommended in this case.

Treatment plan. The patient’s gynecologist performed a hysteroscopic polypectomy that revealed no cancer. Serial monitoring was recommended for the low-risk ovarian cyst. The next ultrasonography scan, at 6 months, was unchanged; a subsequent scan was ordered for 12 months later, and at that time the cyst had resolved.

Share your thoughts! Send your Letter to the Editor to rbarbieri@mdedge.com. Please include your name and the city and state in which you practice.

Pages

Recommended Reading

Leg lymphedema after gynecologic lymphadenectomy exceeds expectations
MDedge ObGyn
VIDEO: Office-based hereditary cancer risk testing is doable
MDedge ObGyn
Universal BRCA testing worthwhile for relatives of high-grade serous ovarian cancer patients
MDedge ObGyn
MDedge Daily News: How Trump’s election affected contraception
MDedge ObGyn
Did unsafe oxytocin dose cause uterine rupture? $3.5M settlement
MDedge ObGyn
Cochrane report: HPV vaccine proves its worth in adolescent, young adult women
MDedge ObGyn
MDedge Daily News: Do HPV vaccines really cut cancer risk?
MDedge ObGyn
Is adjuvant chemo warranted in stage I ovarian clear cell carcinoma?
MDedge ObGyn
Should breast cancer screening guidelines be tailored to a patient’s race and ethnicity?
MDedge ObGyn
Endometrial cancer survivors may need long-term cardiovascular monitoring
MDedge ObGyn